NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors

by Nicolas Duployez, Guillaume Grzych, Benoît Ducourneau, Martin Alarcon Fuentes, Nathalie Grardel, Thomas Boyer, Wadih Abou Chahla, Bénédicte Bruno, Brigitte Nelken, Emmanuelle Clappier, Claude Preudhomme
Published 2016-04-01